|
||||||||
|
||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
CSTE Position Statement Number: 10-ID-07
An acute illness with a) discrete onset of symptoms and b) jaundice, dark urine or elevated serum aminotransferase levels (ALT) >200 IU/L
Immunoglobulin M (IgM) antibody to hepatitis A virus (anti-HAV) positive
or
a case that meets the clinical case definition and occurs in a person who has an epidemiologic link with a person who has laboratory-confirmed hepatitis A (i.e., household or sexual contact with an infected person during the 15-50 days before the onset of symptoms)
Privacy Policy | Accessibility CDC Home | Search | Health Topics A-Z This page last updated November 17, 2011 United States
Department of Health and Human Services |